HIGHLIGHTS
- who: Mudhar N. Hasan from the Division of Urology, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden Sorbonne Université, GRC n°5, ONCOTYPE‑URO, AP‑HP, Hôpital Pitié‑Salpêtrière, Paris, France Bristol Urological Institute, Southmead Hospital, Bristol, England, UK have published the paper: Consultation on UTUC, Stockholm 2018 aspects of risk stratification: long-term results and follow-up, in the Journal: (JOURNAL)
- what: In the investigations that did consider this technique, holmium (Ho):YAG and Ho:YAG in combination with Neodymium:YAG was applied most often. The overall goal of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.